Eli Lilly Engages in Advanced Talks to Acquire Ventyx Biosciences for Over $1 Billion
Eli Lilly is in advanced discussions to purchase Ventyx Biosciences for over $1 billion, according to a Wall Street Journal report. The news prompted a 5.2% rise in Ventyx's share price, reflecting investor confidence.
Insights:
Eli Lilly and Company is reportedly in advanced negotiations to acquire Ventyx Biosciences Inc for a sum exceeding $1 billion. This development was revealed by the Wall Street Journal on January 6, 2026, citing sources familiar with the matter. Following the report, Ventyx's share price surged by 5.2%, indicating a positive market reaction and investor confidence in the potential transaction.
